Devita, Hellman, and Rosenberg's Cancer

LWBK1006-47 LWW-Govindan-Review December 12, 2011 20:55

CHAPTER 47 SOCIETAL ISSUES IN

ONCOLOGY

THOMAS H. FONG

DIRECTIONS Each of the numbered items below is followed by lettered answers. Select the

ONE lettered answer that is BEST in each case unless instructed otherwise.

QUESTIONS

Question 47.1. Which of the following is NOT an element of valid informed consent?

A. Competence or mental capacity

B. Disclosure of information relevant to the decision

C. Assurance of favorable outcome from treatment

D. Voluntariness of choice, free from excessive pressure

Question 47.2. Surrogates should decide which interventions to provide a patient who

cannot give informed consent for himself/herself according to what stan-

dards?

A. Substituted judgment (predicting patient’s treatment preference, if

competent)

B. Best interest of the patient

C. Best interest of the patient’s family

D. Both A and B

Question 47.3. Institutional review boards review proposed clinical trials to ensure that

research trials with human beings meet all of the following requirements,

EXCEPT which one?

A. Financial incentive for subject

B. Scientific validity

C. Favorable risk–benefit ratio

D. Fair subject selection

Corresponding Chapters inCancer: Principles & Practice of Oncology,Ninth Edition: 178 (Regulatory Issues),

179 (Health Disparities in Cancer), 180 (Cancer Information on the Internet), and 181 (Complementary, Alternative,

and Integrative Therapies in Cancer Care).

581